Advos

AI Maverick Intel issued 76.5 million shares as initial consideration for its proposed acquisition of HEAL Access Canada, reducing total consideration to 100 million shares and planning an OTCQB uplisting.

Nevada Organic Phosphate Inc. has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, aiming to evaluate phosphate grade characteristics at depth.

LaFleur Minerals announced broad gold intercepts from its ongoing drilling program at the Swanson Gold Project, confirming continuous mineralization and supporting expansion beyond current resource models and planned open-pit limits.

Bullish (NYSE: BLSH) has agreed to acquire Equiniti, parent of Notified and a global transfer agent, for $4.2 billion to create a platform for tokenized securities and bridge traditional finance with blockchain.

SPARC AI Inc. is highlighted in an AINewsWire editorial discussing the rise of software-driven autonomy in drone warfare, emphasizing its GPS-denied navigation and targeting platform.

Lunai Bioworks has filed a securities fraud lawsuit alleging unidentified naked short sellers manipulated its stock through massive failures to deliver shares, potentially impacting investor confidence and market integrity.

MindBio Therapeutics is developing an AI-driven voice analysis platform for real-time drug and alcohol intoxication detection, with potential applications in law enforcement, workplace safety, and healthcare, as highlighted in a BioMedWire editorial.

Oncotelic Therapeutics is featured in a BioMedWire editorial highlighting its intranasal nose-to-brain delivery platform as a key innovation for overcoming the blood-brain barrier, opening opportunities in neurological disease and biodefense.

SPARC AI Inc. was highlighted in an AINewsWire editorial discussing the critical role of software-driven autonomy in modern drone warfare, emphasizing its GPS-denied navigation solution for military drones.

Stonegate Capital Partners updates coverage on Viemed Healthcare, highlighting improving revenue mix, stronger free cash flow conversion, and growth in sleep and resupply segments.

MindBio Therapeutics CEO Justin Hanka appeared on the TechMediaWire Podcast to discuss the company's AI-driven voice analysis technology for detecting drug and alcohol intoxication, focusing on its potential to improve safety in regulated workplaces like mining.

SureNano Science Ltd. highlights its subsidiary GlucaPharm Inc. and the GEP-44 triple agonist peptide in a BioMedWire editorial, addressing the growing demand for improved obesity and metabolic disease treatments.

Tonix Pharmaceuticals reported Q1 2026 financial results highlighting commercial progress for its newly launched fibromyalgia treatment TONMYA and positive Phase 1 data for a Lyme disease prevention candidate.

Lantern Pharma (NASDAQ: LTRN) will announce its first-quarter 2026 operating and financial results on May 15, providing updates on clinical trials and AI platform development.

Qdrant's vector search infrastructure enables Sapu's AI platform to index and query all 28 million PubMed abstracts, accelerating biomedical discovery and contributing to seven peer-reviewed papers.

Premier Graphene Inc. has successfully delivered its initial military order to Mexico's Secretaría de la Defensa Nacional, positioning the company for follow-on defense supply opportunities across Latin America.

American Shared Hospital Services will report first quarter 2026 financial results on May 14, with a conference call to discuss the results at 12:00 pm ET.